Bensalem, Pa. – September 10, 2026 -- The Law Offices of Howard G. Smith announced a securities fraud class action against Hims & Hers Health, Inc. (NYSE: HIMS), setting a November 2, 2026 lead plaintiff deadline for investors seeking to lead the case.
Class period spans August 2025 to July 2026 covering alleged misstatements
The lawsuit covers purchases of Hims & Hers stock between August 4, 2025, and July 29, 2026. Plaintiffs allege the telehealth company failed to disclose that it shared consumers' health information with third-party advertising platforms.
Complaint alleges patients were charged before medical consultations
The filing claims Hims & Hers charged consumers for prescriptions almost immediately after intake form submission, despite marketing statements promising patients a consultation with a medical provider to find treatment "right for them."
Regulatory scrutiny and potential penalties cited as undisclosed risks
According to the complaint, this conduct exposed the company to regulatory scrutiny and made it reasonably likely to incur fees and penalties, rendering prior public statements about its business and prospects materially misleading.
Investors who suffered losses on Hims & Hers shares during the class period have until November 2, 2026, to contact the Law Offices of Howard G. Smith to seek lead plaintiff status. Class members need not take action to remain part of the litigation and may retain counsel of their choice.